ELEVATE-HFpEF Clinical Study (NCT06678841)
Randomized Trial of ELEVATEd Cardiac Pacing Rate for Personalized Treatment of Heart Failure With Preserved Ejection Fraction (ELEVATE-HFpEF)
🩺 Plain-English Summary (8th-Grade Level)
ELEVATE-HFpEF is a prospective, randomized, controlled, double-blinded, multi-center, global, interventional pivotal study evaluating the safety and efficacy of dual chamber personalized pacing compared to minimal or no pacing for the treatment of patients with heart failure with preserved ejection fraction (HFpEF).
Who can join: Review the eligibility criteria below.
Location: Banner - University Medical Center Phoenix — Phoenix, Arizona
Age range: 40 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (50 Sites)
Showing the first 25 of 50 sites.
- Banner - University Medical Center Phoenix — Phoenix, Arizona
- Sutter Health Hospital — San Francisco, California
- Hartford Hospital — Hartford, Connecticut
- Cardiovascular Institute of Northwest Florida — Panama City, Florida
- Emory University — Atlanta, Georgia
- The University of Chicago Medical Center — Chicago, Illinois
- University of Kansas Medical Center — Kansas City, Kansas
- Norton Healthcare — Louisville, Kentucky
- Cardiovascular Institute of the South — Houma, Louisiana
- Tufts Medical Center — Boston, Massachusetts
- M Health Fairview University of Minnesota Medical Center - East Bank — Minneapolis, Minnesota
- Saint Lukes Mid America Heart Institute — Kansas City, Missouri
- Duke University Medical Center — Durham, North Carolina
- The Ohio State University Wexner Medical Center — Columbus, Ohio
- Mount Carmel East — Columbus, Ohio
- Lancaster General Hospital — Lancaster, Pennsylvania
- Lankenau Institute for Medical Research — Wynnewood, Pennsylvania
- Medical University of South Carolina (MUSC) — Charleston, South Carolina
- Saint Thomas Research Institute — Nashville, Tennessee
- Dallas VA Medical Center — Dallas, Texas
- Texas Health Research & Education Institute — Fort Worth, Texas
- The University of Vermont Medical Center — Burlington, Vermont
- Inova Fairfax Hospital — Falls Church, Virginia
- Saint Joseph Medical Center (Tacoma WA) — Tacoma, Washington
- Charleston Area Medical Center (CAMC) Memorial Hospital — Charleston, West Virginia
📞 Contact the Study Coordinator
Phone: (954) 682-8334
Email: dawn.dyer@medtronic.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Heart Failure With Preserved Ejection Fraction (HFpEF)
- Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study — Phoenix, Arizona
- A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF — Fairhope, Alabama
- Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) — Chicago, Illinois
- Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection Fraction — Gainesville, Florida
Explore by condition: All Heart Failure With Preserved Ejection Fraction (HFpEF) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.